Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: “Bioidentical hormone replacement therapy” (BHRT) can relieve menopausal symptoms and improve quality of life for many people, but it is not inherently safer than conventional hormone therapy. Most major medical organizations advise caution — especially for compounded products — and recommend using FDA‑approved hormones whenever possible and tailoring treatment to each person’s risks and needs.

What BHRT means

• “Bioidentical” refers to hormones that are chemically identical to human hormones (examples: 17β‑estradiol, micronized progesterone).
• In practice BHRT is used in two ways: (1) FDA‑approved products that are bioidentical (for example estradiol patches/creams and micronized progesterone), and (2) compounded, custom formulations made by compounding pharmacies (often promoted as “natural” or “tailored”).

What doctors and major organizations say

• ACOG (American College of Obstetricians and Gynecologists), the Endocrine Society, and the North American Menopause Society (NAMS) do not endorse claims that compounded BHRT is safer or more effective than FDA‑approved products. They caution against routine use of compounded hormone preparations because of variable potency, limited testing, and lack of long‑term safety data.
• The FDA has warned about unapproved compounded hormones and marketing claims that overstate safety or benefits.

Benefits and evidence

• Hormone therapy (HT) — whether bioidentical or not — is the most effective treatment for moderate‑to‑severe hot flashes and can help with vaginal atrophy and some bone loss.
• Evidence does not show a clear advantage for compounded BHRT over FDA‑approved alternatives for symptom relief.

Risks

• Risks are essentially the same as for conventional HT and depend on the hormone type, dose, route, whether a progestogen is used, and patient factors (age, time since menopause, personal and family history). Major concerns include increased risk (in some groups) of blood clots, stroke, and (with combined estrogen–progestin) breast cancer.
• “Natural” labeling or bioidentical chemistry does not eliminate those risks.
• Compounded products may have inconsistent potency, contamination risk, and lack the manufacturing oversight and clinical trial data required for FDA approval.

Practical takeaways / what doctors usually do

• Prefer FDA‑approved products when available: examples include estradiol patches (Vivelle‑Dot, Climara, Alora), oral estradiol (Estrace), combined estrogen–progestin patches (CombiPatch), and micronized progesterone (Prometrium). These have standardized dosing, manufacturing oversight, and more safety data.
• For women with a uterus, doctors usually give a progestogen along with systemic estrogen to prevent endometrial cancer (micronized progesterone/Prometrium is a bioidentical option).
• Consider route of delivery: transdermal (patch/gel) estrogen may have lower risk of blood clots than some oral estrogens in some studies.
• If a patient is interested in compounded BHRT, physicians usually counsel about the limitations (lack of guaranteed dose/purity, limited evidence) and, if used, recommend a reputable compounding pharmacy and regular monitoring.
• Saliva testing is not a reliable method to guide dosing and is not recommended for routine BHRT management.

Alternatives and monitoring

• Nonhormonal options for hot flashes include paroxetine (Brisdelle — an FDA‑labeled option for hot flashes), other SSRIs/SNRIs, gabapentin, and lifestyle measures.
• If you start HT/BHRT, doctors typically use the lowest effective dose, reassess symptoms and risks regularly, continue recommended screening (mammograms), and monitor blood pressure and any relevant labs.

If you’re considering BHRT

• Discuss your symptoms and goals with a clinician experienced in menopause care. Ask for a personalized risk assessment (breast cancer risk, clotting history, heart disease).
• Ask whether an FDA‑approved bioidentical option is available for your needs before choosing a compounded product.
• If your provider recommends compounded BHRT, ask about the pharmacy’s quality controls (USP compliance, batch testing) and what monitoring they will do.

If you want, I can help:

• Draft questions to bring to your clinician, or
• Summarize pros/cons for a specific product or scenario (e.g., postmenopausal hot flashes, hysterectomy, testosterone for low libido).